Concord Historical Balance Sheet
CCM Stock | USD 4.44 0.01 0.22% |
Trend analysis of Concord Medical Services balance sheet accounts such as Other Current Liab of 752.2 M, Total Current Liabilities of 2 B or Other Liab of 324.7 M provides information on Concord Medical's total assets, liabilities, and equity, which is the actual value of Concord Medical Services to its prevalent stockholders. By breaking down trends over time using Concord Medical balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Concord Medical Services latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Concord Medical Services is a good buy for the upcoming year.
Concord Medical Inventory |
|
Concord |
About Concord Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Concord Medical Services at a specified time, usually calculated after every quarter, six months, or one year. Concord Medical Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Concord Medical and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Concord currently owns. An asset can also be divided into two categories, current and non-current.
Concord Medical Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Concord Medical assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Concord Medical Services books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Concord Medical balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Concord Medical Services are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Most accounts from Concord Medical's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Concord Medical Services current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. At this time, Concord Medical's Total Liabilities is very stable compared to the past year. As of the 25th of November 2024, Intangible Assets is likely to grow to about 435.8 M, though Total Stockholder Equity is likely to grow to (2 B).
2021 | 2022 | 2023 | 2024 (projected) | Other Current Liabilities | 646.0M | 397.2M | 716.3M | 752.2M | Total Assets | 6.2B | 6.0B | 6.1B | 4.0B |
Concord Medical balance sheet Correlations
Click cells to compare fundamentals
Concord Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Concord Medical balance sheet Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 4.3B | 5.3B | 6.2B | 6.0B | 6.1B | 4.0B | |
Other Current Liab | 274.7M | 243.2M | 646.0M | 397.2M | 716.3M | 752.2M | |
Total Current Liabilities | 627.5M | 512.1M | 804.5M | 1.1B | 2.0B | 2.0B | |
Total Stockholder Equity | (122.8M) | (663.0M) | (1.4B) | (1.9B) | (2.1B) | (2.0B) | |
Other Liab | 287.0M | 270.2M | 230.1M | 268.9M | 309.2M | 324.7M | |
Cash | 74.3M | 334.3M | 157.4M | 158.3M | 58.1M | 55.2M | |
Other Assets | 661.1M | 409.9M | 250.6M | 24.0M | 27.6M | 26.2M | |
Long Term Debt | 1.3B | 2.0B | 2.2B | 2.5B | 2.0B | 2.1B | |
Good Will | 210.4M | 213.7M | 581.9M | 575.4M | 661.7M | 694.8M | |
Common Stock Shares Outstanding | 43.4M | 43.4M | 43.7M | 4.4M | 3.9M | 3.7M | |
Other Current Assets | 4.3M | 31.4M | 258.4M | 386.4M | 445.2M | 467.5M | |
Total Liab | 2.4B | 2.9B | 3.5B | 4.0B | 4.3B | 4.5B | |
Intangible Assets | 532.5M | 522.8M | 1.1B | 762.1M | 323.3M | 435.8M | |
Property Plant Equipment | 2.5B | 3.2B | 3.8B | 3.9B | 4.4B | 4.7B | |
Short Long Term Debt Total | 1.9B | 2.4B | 2.7B | 3.2B | 3.3B | 3.5B | |
Property Plant And Equipment Net | 2.5B | 3.2B | 3.3B | 3.4B | 4.1B | 4.3B | |
Current Deferred Revenue | 3.2M | 87.7M | 81.0M | 100.8M | 59.4M | 32.4M | |
Net Debt | 1.8B | 2.0B | 2.6B | 3.1B | 3.2B | 3.4B | |
Retained Earnings | (1.8B) | (2.5B) | (3.3B) | (3.8B) | (4.1B) | (3.9B) | |
Accounts Payable | 8.3M | 18.6M | 102.5M | 146.7M | 129.2M | 135.7M | |
Non Current Assets Total | 4.0B | 4.7B | 5.6B | 5.2B | 5.4B | 3.3B | |
Non Currrent Assets Other | 661.1M | 107.5M | 13.6M | 23.2M | 11.0M | 10.4M | |
Cash And Short Term Investments | 74.3M | 334.3M | 157.4M | 158.3M | 58.1M | 55.2M | |
Net Receivables | 199.6M | 280.4M | 130.6M | 130.3M | 73.5M | 69.8M | |
Liabilities And Stockholders Equity | 4.3B | 5.3B | 6.2B | 6.0B | 6.1B | 4.3B | |
Non Current Liabilities Total | 1.8B | 2.4B | 2.7B | 2.9B | 2.4B | 1.3B | |
Other Stockholder Equity | 1.8B | 1.8B | 1.9B | 1.9B | 2.0B | 1.7B | |
Property Plant And Equipment Gross | 2.5B | 3.4B | 3.6B | 3.8B | 4.1B | 4.3B | |
Total Current Assets | 282.5M | 676.0M | 584.5M | 759.8M | 617.2M | 736.9M | |
Accumulated Other Comprehensive Income | (97.3M) | (46.4M) | (29.5M) | (27.8M) | (65.4M) | (62.1M) | |
Short Term Debt | 341.3M | 162.5M | 35.1M | 548.5M | 1.1B | 1.1B | |
Short Term Investments | 50M | 35.2M | 25.0M | 2.7M | 2.4M | 2.3M | |
Inventory | 4.3M | 21.6M | 38.1M | 84.8M | 40.3M | 28.3M | |
Net Tangible Assets | (865.7M) | (1.4B) | (2.6B) | (2.8B) | (2.5B) | (2.4B) | |
Long Term Investments | 64.9M | 313.0M | 390.6M | 437.9M | 394.7M | 319.4M | |
Short Long Term Debt | 328.4M | 148.9M | 299.4M | 512.6M | 1.0B | 537.8M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Concord Medical Services. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Concord Medical. If investors know Concord will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Concord Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (11.98) | Revenue Per Share 107.978 | Quarterly Revenue Growth (0.23) | Return On Assets (0.04) | Return On Equity (0.32) |
The market value of Concord Medical Services is measured differently than its book value, which is the value of Concord that is recorded on the company's balance sheet. Investors also form their own opinion of Concord Medical's value that differs from its market value or its book value, called intrinsic value, which is Concord Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Concord Medical's market value can be influenced by many factors that don't directly affect Concord Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Concord Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Concord Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Concord Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.